Insider Selling Ramps Up at Abacus Global Management

Abacus Global Management Inc. has seen a steady uptick in insider selling in the past few weeks, with co‑founder Matthew Ganovsky executing three sizeable sales during the first quarter of September. The most recent trade on September 18th saw Ganovsky divest 24,000 shares at a weighted average of $8.79, slightly above the market close of $8.27. Over the same period, his holdings fell from roughly 8.75 million shares to 8.67 million, a reduction of about 80,000 shares. When combined with similar moves by fellow directors Kevin Scott and Sean McNealy, the company’s insider selling volume has surpassed 72,000 shares in just three days.

What This Means for Investors

The volume of insider sales—especially from key executives—often signals that insiders are looking to diversify their personal portfolios or that they believe the stock is overvalued. For Abacus, the average sale price is consistently above the current market price, suggesting that insiders perceive a temporary mispricing rather than a long‑term bearish view. Still, the timing of these sales coincides with a sharp decline in the stock’s weekly performance (down 8.8 %) and a negative quarterly trend. If the selling pressure continues, it could accelerate a further sell‑off unless balanced by new institutional inflows or a strong earnings release.

Ganovsky’s Trading Profile

A review of Ganovsky’s recent filing history shows a pattern of strategic buying early in the year—most notably a 211,742‑share purchase on March 12th at $10.10—followed by periodic divestitures. His average sale price in September is about $8.10, roughly 15 % below the March purchase price, but still higher than the current market level. Ganovsky has historically maintained a sizable stake (over 8.6 million shares) and tends to sell in tranches of 21k–38k shares, consistent with a Rule 10b5‑1 trading plan. The fact that his recent sales are executed at a premium to the market suggests he may be capitalizing on a perceived valuation peak rather than reacting to an immediate downside concern.

Outlook for the Company

Abacus operates in the niche life‑settlement space, a sector that has experienced volatility as insurers adjust policy‑pool valuations. The company’s market cap of $754 million and a P/E of 29.8 indicate it is still valued at a relatively high multiple. With insider activity indicating a cautious approach to the current price, investors should watch for a potential catalyst—such as a new partnership or regulatory change—that could justify a price rally. Until then, the recent insider selling may keep downward pressure on the share price, especially if the broader market sentiment remains neutral or mildly negative.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
2026-09-18Ganovsky Matthew ()Sell24,000.008.79Common Stock
2026-09-21Ganovsky Matthew ()Sell36,000.008.13Common Stock
2026-09-22Ganovsky Matthew ()Sell21,312.008.01Common Stock
2026-09-18Kirby Kevin Scott ()Sell24,000.008.79Common Stock
2026-09-21Kirby Kevin Scott ()Sell36,400.008.13Common Stock
2026-09-22Kirby Kevin Scott ()Sell21,100.008.01Common Stock
N/AKirby Kevin Scott ()Holding86,207.00N/ACommon Stock
2026-09-18McNealy Sean ()Sell24,000.008.79Common Stock
2026-09-21McNealy Sean ()Sell35,854.008.13Common Stock
2026-09-22McNealy Sean ()Sell21,100.008.01Common Stock
N/AMcNealy Sean ()Holding86,207.00N/ACommon Stock